Is LTR Pharma Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, LTR Pharma Ltd (LTP.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is LTR Pharma Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes LTR Pharma Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of LTR Pharma Ltd?

Muslim investors may consider investing in LTR Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is LTR Pharma Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of LTR Pharma Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for LTR Pharma Ltd updated?

The Shariah compliance status of LTR Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like LTR Pharma Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of LTR Pharma Ltd?

You can check the latest Shariah compliance status of LTR Pharma Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

LTP.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: October 20, 2025

Report Source: 2025 Annual Report

LTR Pharma Ltd. Stock Analysis LTP.AX

Australia Health Care Micro Cap Report: 2025 Annual

LTR Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. The company is headquartered in Brisbane, Queensland. The company went IPO on 2023-12-11. The firm is developing and commercializing therapies that address significant unmet medical needs. The firm is focused on improving men’s health through clinical development and commercialization of nasal spray treatments for erectile dysfunction. Its lead products, SPONTAN and ROXUS, are fast-acting intranasal sprays for the treatment of erectile dysfunction, enabling onset of action in 10 minutes or less. The firm is also advancing OROFLOW, a novel intranasal spray under development for the treatment of Oesophageal Motility Disorders (OMD) - a debilitating group of conditions affecting swallowing function. The firm's subsidiary is LTR Pharma Inc.

Key Statistics of LTR Pharma Ltd (LTP.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.41AUD0.43

Today's Open

AUD0.41

Volume

156.31K

P/E Ratio (TTM)

52 Week Range

AUD0.27AUD0.81

Market Cap

82.71M

Avg. Volume

319.98K

Dividend Yield

Financial Metrics & Statements of LTR Pharma Ltd (LTP.AX)

FAQ's for LTR Pharma Ltd (LTP.AX)

According to Musaffa’s Shariah screening methodology, LTR Pharma Ltd (LTP.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.